
Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.
James A. Simon, MD, CCD, MSCP, IF, FACOG, Clinical Professor of Ob/Gyn at George Washington University in Washington, DC.

Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.